Cambridge, United Kingdom
Application deadline: 13 Feb 2014
has launched a new Postdoctoral training program called ‘Sustaining Innovation’ that aims to maintain and further enhance the company’s excellent scientific culture. Astex is an Industry-leading biotechnology company that pioneered Fragment-Based Drug Discovery to generate multiple novel drug candidates that are now in clinical development. Our scientists have published in the leading scientific journals, such as Nature & Science, and regularly present at major scientific conferences. Astex was recently acquired by Otsuka Pharmaceuticals and now has an excellent foundation to further expand its drug discovery portfolio, capabilities and scientific research.
We now seek to appoint high calibre PhD scientists to perform cutting-edge research in an innovative and dynamic Biotech environment. These Postdoctoral Fellows will be expected to perform exploratory research as part of a multi-disciplinary team and publish in high impact scientific journals. Successful applicants will be highly motivated PhD scientists from one of several research areas including Computational chemistry, Bioinformatics, Structural Biology, Biophysics, Medicinal chemistry and Cancer biology and may also propose their own scientific projects. All positions will be located at the company’s Drug Discovery centre in Cambridge, UK.
For more information on the structural biology positions, please email Jeff.Yon@astx.com